- 全部删除
- 您的购物车当前为空
GSK-LSD1 dihydrochloride (GSK-LSD1 2HCl) 是一种特异性不可逆的 LSD1 抑制剂(IC50: 16 nM)。GSK-LSD1 dihydrochloride 对 LSD1 的选择性是其他密切相关的 FAD 利用酶(即 MAO-A、LSD2、MAO-B)的 1000 倍以上。
GSK-LSD1 dihydrochloride (GSK-LSD1 2HCl) 是一种特异性不可逆的 LSD1 抑制剂(IC50: 16 nM)。GSK-LSD1 dihydrochloride 对 LSD1 的选择性是其他密切相关的 FAD 利用酶(即 MAO-A、LSD2、MAO-B)的 1000 倍以上。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 197 | In stock | |
5 mg | ¥ 579 | In stock | |
10 mg | ¥ 868 | In stock | |
25 mg | ¥ 1,730 | In stock | |
50 mg | ¥ 2,780 | In stock | |
100 mg | ¥ 3,970 | In stock | |
200 mg | ¥ 5,780 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 640 | In stock |
GSK-LSD1 dihydrochloride 相关产品
产品描述 | GSK-LSD1 dihydrochloride (GSK-LSD1 2HCl) is a specificity irreversible LSD1 inhibitor (IC50: 16 nM). The selectivity of GSK-LSD1 for LSD1 is >1000 fold over other closely related FAD utilizing enzymes (i.e. MAO-A, LSD2, MAO-B). |
靶点活性 | LSD1:16 nM |
体外活性 | GSK-LSD1 在癌症细胞系中诱导基因表达变化,平均EC50值< 5 nM,并且以平均EC50值< 5 nM抑制癌细胞系的增长。[1] |
别名 | GSK-LSD1 2HCl, GSK-LSD1 (hydrochloride) |
分子量 | 289.24 |
分子式 | C14H22Cl2N2 |
CAS No. | 2102933-95-7 |
Smiles | Cl.Cl.C1[C@@H](NC2CCNCC2)[C@@H]1c1ccccc1 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 25 mg/mL (86.43 mM), Sonication is recommended. ![]() H2O: 50 mg/mL (172.87 mM), Sonication is recommended. ![]() | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
DMSO/H2O
H2O
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容